Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study
Scandinavian Journal of Urology · 2025
DOI: 10.2340/sju.v60.44187 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Scandinavian Journal of Urology, 2025. Verfasst von Rikke Vilsbøll Milling und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. rimill@rm.dk. Hauptthemen laut MEDLINE: Quality of Life, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objective: Approximately 75% of bladder cancer patients are diagnosed with non-muscle invasive bladder cancer (NMIBC). Complications from treatment, burden the patients and may affect their Quality of Life (QoL). Although accounting for most bladder cancer patients, only 25% of QoL research is conducted in NMIBC patients. The aim is to describe the incidence of complications and to investigate their long-term impact on QoL.
Methods
This is a cross-sectional study using register data combined with a questionnaire, measuring urological, sexual, gastrointestinal, and psychological complications during treatment. The NMIBC patients diagnosed in Denmark from 2015 to 2020 with the ability to receive digital mail were invited to participate along with 1:6 age- and gender-matched controls. The survey mainly consisted of the European Organisation for Research and Treatment of Cancer’s (EORTC) EORTC-QLQ-C30 and the NMIBC specific EORTC-QLQ-NMIBC24.
Results
A total of 2262 (43%) NMIBC-patients and their 4092 (36%) matched controls participated. Mean time since last Transurethral Resection of Bladder Tumour was 5.8 years (SD: 2.2). Both cases and controls scored equally on the functional items and symptom items of the EORTC-QLQ-C30. The scoring by NMIBC-patients of the EORTC-QLQ-NMIBC24 were mild, indicating no symptomatology. No difference in register-based diagnoses was identified, except for higher incidences of infections related to the urinary tract identified in NMIBC patients.
Conclusions
We found that NMIBC patients have higher incidences of urological diagnoses compared to controls, but not in sexual or gastrointestinal diagnoses. No difference in long-term impact of complications on QoL between NMIBC patients and controls were identified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. rimill@rm.dk.
- Department of Urology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Rikke Vilsbøll Milling, Ninna Kjær Nielsen, Charlotte Graugaard-Jensen, Peter Christensen, Helle Pappot, Jørgen Bjerggaard Jensen
Zitieren
APA
Milling, R. V., Nielsen, N. K., Graugaard-Jensen, C., Christensen, P., Pappot, H., & Jensen, J. B. (2025). Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study. Scandinavian Journal of Urology. https://doi.org/10.2340/sju.v60.44187
Vancouver
Milling RV, Nielsen NK, Graugaard-Jensen C, Christensen P, Pappot H, Jensen JB. Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study. Scandinavian Journal of Urology. 2025. doi:10.2340/sju.v60.44187
BibTeX
@article{Milling2025,
author = {Milling, Rikke Vilsbøll and Nielsen, Ninna Kjær and Graugaard-Jensen, Charlotte and Christensen, Peter and Pappot, Helle and Jensen, Jørgen Bjerggaard},
title = {Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study},
journal = {Scandinavian Journal of Urology},
year = {2025},
doi = {10.2340/sju.v60.44187}
}
EUVIMED